WHO Restructures Medicines Department, Including Innovation, Policy 24/06/2013 by Brittany Ngo for Intellectual Property Watch Leave a Comment This summer through September, a restructuring is taking place under the World Health Organization Health Systems and Innovation cluster that has relevance for intellectual property and innovation issues.
WIPO Economics Working Paper On Mobility Of Inventors 21/06/2013 by Intellectual Property Watch Leave a Comment Central American, Caribbean, and African economies have the most “inventor brain drain” in relation to the number of home country inventors, according to a recent working paper released by the World Intellectual Property Organization. Data for the study included information on inventor nationality and residence available in Patent Cooperation Treaty (PCT) applications.
UNICEF Supply Annual Report Highlights Medical Products Access, Innovation 21/06/2013 by Brittany Ngo for Intellectual Property Watch Leave a Comment In its recently released Supply Annual Report for 2012, the United Nations agency UNICEF assessed its programme work in developing and strengthening supply chains, in hopes of achieving equitable access to life-saving supplies for children and women. The report found that UNICEF procured supplies and services valued at $2.468 billion, with India being the largest supplier country to UNICEF in 2012.
European Commission Fines Pharma Companies For Payments To Delay Generic Entry 19/06/2013 by Brittany Ngo for Intellectual Property Watch 1 Comment The European Commission (EC) has fined Danish pharmaceutical company Lundbeck as well as eight other generic manufacturers for delaying market entry of generic medicines by way of patent settlement agreements (also known as “pay-for-delay” agreements).
The Impact Of Derailing The WHO Medical R&D Convention 19/06/2013 by Intellectual Property Watch 1 Comment An article in the newly launched Journal of Health Diplomacy about the stalled progress at the World Health Organization for a medical research and development (R&D) convention discusses systemic failures in global health policy.
WIPO Seminar Discusses Impact Of TRIPS On Pharmaceutical Innovation 19/06/2013 by Brittany Ngo for Intellectual Property Watch Leave a Comment The latest instalment of the World Intellectual Property Organization seminar series titled “The Economics of Intellectual Property” covered the issue of product patents in the pharmaceutical industry. Discussion focussed on the economics of intellectual property rights and how pharmaceutical patent protection might not be the sole culprit in the access to innovation problem.
Group Of Experts Looks At High Price Of Cancer Drugs 17/06/2013 by Intellectual Property Watch Leave a Comment Prices of cancer drugs must be lowered to be affordable for patients and to maintain sound long-term healthcare policies, according to a group of chronic myeloid leukemia (CML) experts in a recent Blood journal editorial.
Myriad Case Decided: Natural Human Genes Not Patentable In US 14/06/2013 by Intellectual Property Watch 3 Comments The United States Supreme Court came to a decision yesterday on the case of Association for Molecular Pathology v. Myriad Genetics, Inc., striking down Myriad’s patent on isolating human genes from the bloodstream.
WHO Updates Guidance For Pandemic Flu Risk Management 13/06/2013 by Intellectual Property Watch 2 Comments The World Health Organization (WHO) has released an updated guidance document on pandemic influenza risk management, which includes the Pandemic Influenza Preparedness (PIP) Framework for the sharing of influenza viruses and access to vaccines and other benefits that was discussed by member states during the 66th World Health Assembly (WHA) in May.
Geneva Study Finds ‘Evergreening’ Increases Healthcare Costs 12/06/2013 by Intellectual Property Watch 2 Comments A recent Geneva-based study found that so-called evergreening practices utilised by drug manufacturers are successful in protecting profits by maintaining company market share and offsetting generic competition and cost containment policies.